American Renal Associates Holdings, Inc
ARA
ARA was delisted on the 25th of January, 2021.
0 hedge funds and large institutions have $0 invested in American Renal Associates Holdings, Inc in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 67 closing their positions.
100% less funds holding
Funds holding: 67 → 0 (-67)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $323M → $0 (-$323M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 67
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
Centerbridge Partners
New York
|
-$202M |
| 2 |
VBA
Van Berkom & Associates
Montreal,
Quebec, Canada
|
-$24.9M |
| 3 |
BlackRock
New York
|
-$11.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.63M |
| 5 |
Renaissance Technologies
New York
|
-$9.44M |
ARA Hedge Fund Activity: Q1 2021 in Review
0 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q1 2021, worth a combined $0 — down 100% from $323M a quarter earlier.
Sellers outnumbered buyers: 67 funds closed out of ARA and 0 opened new positions — a net loss of 67 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Centerbridge Partners, exiting entirely with an estimated $202M sold.
- 0 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q1 2021, down from 67 in Q4 2020.
- Funds reported $0 of American Renal Associates Holdings, Inc stock for Q1 2021, down 100% quarter-over-quarter.
- 0 funds opened new American Renal Associates Holdings, Inc positions in Q1 2021 and 67 closed out, a net change of -67 holders.
- The largest American Renal Associates Holdings, Inc seller in Q1 2021 was Centerbridge Partners, an estimated $202M sold.
Based on aggregated 13F filings for Q1 2021.